CF PHARMTECH (02652) spent HK$738,700 to repurchase 37,500 shares on May 27th.
Changfeng Pharmaceutical (02652) announced on May 27, 2026, the company purchased 37,500 shares for 738,700 Hong Kong dollars.
CF PHARMTECH (02652) announced on May 27, 2026 that the company will spend 738,700 Hong Kong dollars to repurchase 37,500 shares.
Related Articles
.png)
JIUMAOJIU (09922) repurchased 427,000 shares for HK$650,800 on May 27th.
QYUNS-B (02509) has just completed the first subject dosed in the Phase I clinical trial of QX031N and received a milestone payment from Roche.
TRANSTHERA-B (02617) has completed the issuance of a total of 3.836 million shares of placement shares.
JIUMAOJIU (09922) repurchased 427,000 shares for HK$650,800 on May 27th.
QYUNS-B (02509) has just completed the first subject dosed in the Phase I clinical trial of QX031N and received a milestone payment from Roche.
TRANSTHERA-B (02617) has completed the issuance of a total of 3.836 million shares of placement shares.
